Zhao et al., 2022 - Google Patents
PACTS-assisted thermal proteome profiling for use in identifying peptide-interacting proteinsZhao et al., 2022
View PDF- Document ID
- 13660318633374990261
- Author
- Zhao T
- Tian J
- Wang X
- Hao Y
- Xu M
- Zhao Y
- Liu X
- Chen Y
- Jia C
- Publication year
- Publication venue
- Analytical Chemistry
External Links
Snippet
Bioactive peptides play important roles in various biological processes. However, the traditional methods for profiling the peptide-interacting proteins require modifications to the peptide molecules, often leading to false identifications. We found that the interaction …
- 102000004169 proteins and genes 0 title abstract description 265
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment | |
Mackeh et al. | Autophagy and microtubules–new story, old players | |
Fiesel et al. | Structural and functional impact of parkinson disease‐associated mutations in the E3 ubiquitin ligase parkin | |
Thinon et al. | N-myristoyltransferase inhibition induces ER-stress, cell cycle arrest, and apoptosis in cancer cells | |
Jang et al. | Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers | |
Yang et al. | The fasted/fed mouse metabolic acetylome: N6-acetylation differences suggest acetylation coordinates organ-specific fuel switching | |
Delisle et al. | Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C | |
Parker et al. | Chemical proteomics identifies SLC25A20 as a functional target of the ingenol class of actinic keratosis drugs | |
Dewey et al. | Molecular glue discovery: current and future approaches | |
Shen et al. | cAMP activates TRPC6 channels via the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (PKB)-mitogen-activated protein kinase kinase (MEK)-ERK1/2 signaling pathway | |
Fred et al. | Pharmacologically diverse antidepressants facilitate TRKB receptor activation by disrupting its interaction with the endocytic adaptor complex AP-2 | |
Pilkington et al. | Profiling the serum protein corona of fibrillar human islet amyloid polypeptide | |
Xiao et al. | Site-specific quantification of surface N-glycoproteins in statin-treated liver cells | |
Saha et al. | Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins | |
Prior et al. | Quantitative proteomic analysis of the adipocyte plasma membrane | |
Geer Wallace et al. | Discovery of manassantin A protein targets using large-scale protein folding and stability measurements | |
Cholewa et al. | Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAFV600E mutant melanoma cells | |
Langer et al. | Structure of substrate-bound SMG1-8-9 kinase complex reveals molecular basis for phosphorylation specificity | |
Heydt et al. | Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence | |
Wang et al. | REV7 has a dynamic adaptor region to accommodate small GTPase RAN/Shigella IpaB ligands, and its activity is regulated by the RanGTP/GDP switch | |
Das et al. | Arabinosyltransferase C enzyme of Mycobacterium tuberculosis, a potential drug target: An insight from molecular docking study | |
Cabaud-Gibouin et al. | Heat-shock proteins in leukemia and lymphoma: multitargets for innovative therapeutic approaches | |
Borotto et al. | Increased β-sheet dynamics and D–E loop repositioning are necessary for cu (II)-induced amyloid formation by β-2-microglobulin | |
Zhao et al. | PACTS-assisted thermal proteome profiling for use in identifying peptide-interacting proteins | |
Nandi et al. | Succinylation is a gain-of-function modification in human lens αb-crystallin |